Status
Conditions
Treatments
About
The effects of art on health and well-being have been the subject of increasing exploration in recent years. In 2019, the World Health Organization proposed a literature review analyzing the links between art, health (defined as a state of good functioning) and well-being. Currently, the majority of research has focused on populations presenting pathologies (somatic, neurological or psychiatric), very often in older adults. Furthermore, exposure to art (unlike the practice of an artistic activity) still remains under-investigated. However, recent publications (review and longitudinal study) suggest that attending museums would be associated with an increase in well-being, in people with or without pathology.
Supported by the Blood & Brain @ Caen Normandy Scientific Interest Group and the Museum of Fine Arts as part of the Millennium festivities of the city of Caen, the partnership between three Caen laboratories and a Parisian laboratory enabled the drawing of this innovative research which will aim to measure the effects of visiting a museum dedicated to painting on well-being in healthy adults. It will also involve identifying the cerebral, cognitive and socio-emotional processes associated with these effects, via comprehensive and ecologically adapted measurements.
Through understanding the mechanisms specific to exposure to art which promote well-being, this research could have implications for:
Full description
Call for volunteers:
An A5 information poster will be distributed in various structures in the Caen region but also through the press. Participants will be able to contact a member of the research team by email. They will then be contacted in response to this email in order to arrange a telephone appointment. The purpose of this preliminary telephone interview will be to ensure the inclusion criteria without collecting the personal data relating to them. This is to avoid unnecessary travel. If the participant can be included, then a physical appointment will be offered to them in order to carry out the inclusion visit.
Inclusion visit:
An inclusion visit will be carried out during which the participant will be informed of the progress of the study, its implications and their right of withdrawal. A test of the different devices (Near InfraRed Spectroscopy (NIRS), eye-tracking glasses, skin conductance bracelet) under the same conditions as those of the study will be carried out. Then, the participant's consent will be collected via a written form. Finally, the participant will fill out an admission questionnaire with socio-demographic questions, questions related to the aforementioned inclusion criteria, and questions about their cultural practices. Only for participants over 55 years old, an assessment via the Montreal Cognitive Assessment (MoCA - screening tool for mild neurocognitive impairment) will be carried out. At the end of all these acts, the participant will be assigned an inclusion number. The personal data collected will be stored on a single computer at Cyceron.
Visit 1 to the Museum of Fine Arts in Caen:
Experimental groups Participants in the experimental groups will be randomized into two groups: with or without mediation.
Regardless of their group, they will see the same number of tables. The measurements and questionnaires they will answer will be identical. Upon arrival, participants will be welcomed and then:
Control group The participants in the control group will visit the museum according to a pre-established route with the same number of paintings as the experimental groups. The duration of viewing each painting will be controlled to be identical to that of the experimental groups, i.e. 2 minutes. On the other hand, they will not wear any device (NIRS, eye tracking and electrodermal bracelet) and will not have mediation. They will answer the same questionnaires and cognitive tasks as the experimental groups: before and after the visit, as well as the affect grid during the visit.
Visit 2 to the Museum of Fine Arts in Caen:
For the experimental groups, the changes between visits 1 and 2 will be as follows:
Number of patients
The questionnaires (except empathy and creativity measured only during visit 1), the cognitive tasks and the measurements (oculometric via eye-tracking/ brain activity via NIRS/ cardiac activity (heart rate via the bracelet) will be carried out in the same way as during visit 1.
For the control group:
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
200 participants in 3 patient groups
Loading...
Central trial contact
Denis Vivien, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal